Daymark Health is thrilled to announce the successful closing of an $11.5 million funding round, a significant milestone that marks a new era in value-based oncology care. As a trailblazer in redefining the cancer care experience, Daymark Health leverages its comprehensive, personalized platform to empower patients, support providers, and engage health plans. The infusion of capital will accelerate the expansion of its groundbreaking care model, which seamlessly integrates dedicated care navigation, symptom-focused support, behavioral health care, and essential social resources. Under the leadership of CEO Dr. Justin Bekelman—a pioneer in transforming cancer care—Daymark is committed to advancing a system where patient needs are met holistically and with unparalleled precision.
This funding will support the deployment of innovative, evidence-based health interventions, the further development of its hybrid in-person and virtual care model, and the enhancement of integrated support services. By bridging the gaps in traditional cancer care delivery, Daymark Health is setting a new standard that emphasizes personalized treatment trajectories, patient empowerment, and improved outcomes. The vision is clear: to transform the cancer care experience into one that is more responsive, compassionate, and outcome-driven for patients and their families. Backed by Maverick Ventures and emerging from the innovative Healthcare Foundry platform, Daymark is primed to redefine oncology care. The new capital not only affirms the commitment of key investors but also paves the way for groundbreaking advances that will reshape how cancer care is delivered, ensuring that every patient receives the comprehensive and supportive care they deserve.
